Infliximab 5 mg/kg vs infliximab 10 mg/kg
Induction of 70‐point clinical response CDAI · Patients with active Crohn's disease
It is very uncertain whether infliximab 5 mg/kg changes clinical response defined as reduction in CDAI by 70 points at week 4 compared with infliximab 10 mg/kg (very low certainty).
1 finding from 1 review
- Infliximab for medical induction of remission in Crohn's disease 2023 · Cochrane Headline outcomes onlyRR 1.63 [1.08, 2.46]1 study · 55 participantsVery low